GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Republic Healthcare 8357.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.20

-0.50%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SGD, from our data supplier.

FY2024

Revenue

SGD 8.7m

FY2016FY2024

Net income

−SGD 178,200

FY2016FY2024

Free cash flow

SGD 51,300

FY2016FY2024

Shareholders' equity

SGD 12.6m

FY2016FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSGD 8.7mSGD 10.0mSGD 9.0mSGD 13.4mSGD 13.7mSGD 13.5mSGD 10.4mSGD 10.0mSGD 7.1m
Gross profitSGD 5.9mSGD 6.8mSGD 6.0mSGD 9.1mSGD 9.6mSGD 9.4mSGD 7.1mSGD 7.0mSGD 5.2m
Operating income−SGD 270,500−SGD 775,700−SGD 1.0m−SGD 1.3m−SGD 950,600SGD 1.1mSGD 1.7mSGD 2.9mSGD 2.3m
Net income−SGD 178,200−SGD 855,100−SGD 1.5m−SGD 997,900−SGD 143,600SGD 637,600−SGD 730,600SGD 2.0mSGD 2.0m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.000.00-0.000.010.01

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSGD 14.5mSGD 15.6mSGD 16.3mSGD 19.3mSGD 19.3mSGD 18.6mSGD 14.2mSGD 3.8mSGD 3.3m
Cash and short-term investmentsSGD 11.4mSGD 11.9mSGD 11.8mSGD 14.3mSGD 13.1mSGD 13.9mSGD 12.4mSGD 2.0mSGD 2.1m
Total liabilitiesSGD 1.9mSGD 2.9mSGD 2.7mSGD 3.7mSGD 6.3mSGD 5.4mSGD 1.6mSGD 2.1mSGD 1.4m
DebtSGD 758,700SGD 961,200SGD 810,500SGD 1.5mSGD 2.8mSGD 2.5m———
Shareholders' equitySGD 12.6mSGD 12.8mSGD 13.6mSGD 15.6mSGD 13.0mSGD 13.2mSGD 12.6mSGD 1.7mSGD 1.9m
Shares outstanding624m624m624m551m520m520m461m390m390m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSGD 125,100SGD 899,900−SGD 734,500−SGD 512,600SGD 529,900SGD 2.7m−SGD 250,300SGD 3.0mSGD 1.9m
Capital spending−SGD 73,800−SGD 82,700−SGD 423,400−SGD 619,700−SGD 538,900−SGD 599,200−SGD 418,700−SGD 576,900−SGD 352,200
Free cash flowSGD 51,300SGD 817,200−SGD 1.2m−SGD 1.1m−SGD 9,000SGD 2.1m−SGD 669,000SGD 2.4mSGD 1.5m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022
RevenueSGD 3.7mSGD 4.2mSGD 4.5mSGD 2.1mSGD 2.5mSGD 5.4mSGD 2.9mSGD 2.6m
Gross profitSGD 2.5mSGD 2.8mSGD 3.1mSGD 1.7mSGD 1.7mSGD 3.5mSGD 1.8mSGD 1.8m
Operating income−SGD 1.2mSGD 71,800−SGD 124,500−SGD 120,100−SGD 141,400−SGD 233,300−SGD 94,500−SGD 61,800
Net income−SGD 1.2m−SGD 29,000−SGD 149,200−SGD 435,400−SGD 158,600−SGD 261,100−SGD 104,700−SGD 290,600
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assetsSGD 13.7mSGD 14.5mSGD 14.9mSGD 15.6m—SGD 16.5m—SGD 16.3m
Cash and short-term investmentsSGD 9.6mSGD 11.4mSGD 12.1mSGD 11.9mSGD 12.0mSGD 11.5mSGD 12.3mSGD 11.8m
DebtSGD 764,700SGD 401,800SGD 278,600SGD 471,200—SGD 397,300—SGD 382,300
Shareholders' equitySGD 11.3mSGD 12.6mSGD 12.6mSGD 12.8mSGD 13.9mSGD 13.9mSGD 14.1mSGD 13.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-13.5%-8.5%—
Operating income-40.3%——
Net income-43.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin68.2%67.8%68.7%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-36.4-11.1-11.4-33.2-49.511.4-12.5
Price to sales0.80.91.92.50.50.50.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.